Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,006 public trials 1,218 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

ASP8374 + Cemiplimab in Recurrent Glioma

NCT04826393

Conditions
Astrocytoma, Glioblastoma, Glioma, +16 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • University of Cincinnati Medical Center Cincinnati, Ohio, United States
  • Hospital of the University of Pennsylvania, Abramson Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010)

NCT05665595

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations
  • Moores Cancer Center ( Site 0116) La Jolla, California, United States
  • The Angeles Clinic and Research Institute - West Los Angeles Office ( Site 0123) Los Angeles, California, United States
  • UCLA Hematology/Oncology - Westwood (Building 100) ( Site 0131) Los Angeles, California, United States
  • California Pacific Medical Center - Pacific Campus ( Site 0111) San Francisco, California, United States
View all 205 locations
View Trial Details
Completed

A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors

NCT05293496

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +53 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
View Trial Details
Completed

Clinical Trial to Assess the Efficacy and Safety of 'Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea

NCT00807027

Conditions
Astrocytoma, Glioblastoma, Glioma, +7 more
Locations
  • Hanyang University Guri Hospital Guri-si, Gyeonggi-do, South Korea
  • Gyunghee University Medical Center Seoul, South Korea
  • Konkuk University Seoul, South Korea
  • Korea University Anam Hospital Seoul, South Korea
View Trial Details
Completed

Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced Malignancies

NCT04370704

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • H Lee Moffitt Cancer Center and Research Tampa, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
View all 17 locations
View Trial Details

Related conditions